Physician profile
Emily Cisek
NPI 1518158740
$1,118.57
in general payments reported to CMS, 2019-2025
23 companies · $10.00 in 2025
The $10.00 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $439 · 2020: $294 · 2021: $310 · 2022: $65.38 · 2025: $10.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $219.41 | 2019-2022 | |
| Therapeuticsmd, INC. | $202.99 | 2019-2021 | |
| Exeltis, USA INC. | $81.55 | 2020-2021 | |
| Coopersurgical, INC. | $75.85 | 2019-2021 | |
| Amag Pharmaceuticals, INC. | $59.83 | 2019 | |
| Avion Pharmaceuticals | $51.01 | 2020-2021 | |
| Hologic Sales and Service, LLC | $50.71 | 2019-2021 | |
| Organon LLC | $40.16 | 2021-2025 | Jada System |
| Daiichi Sankyo INC. | $37.87 | 2019 | |
| Minerva Surgical, INC | $36.28 | 2020-2021 | |
| Amgen INC. | $35.35 | 2019 | |
| Mylan Pharmaceuticals INC. | $27.96 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $26.67 | 2019-2020 | |
| Allergan, INC. | $23.80 | 2019 | |
| Evofem Biosciences, INC. | $22.51 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medicem INC. | $21.95 | 2020 | |
| Aspira Women'S Health INC | $17.65 | 2021 | |
| Boston Scientific Corporation | $17.11 | 2019 | |
| Pfizer INC. | $16.19 | 2020 | |
| Smith+Nephew, INC. | $15.63 | 2019 | |
| Mayne Pharma Commercial LLC | $13.23 | 2021 | |
| Mission Pharmacal Company | $12.72 | 2020 | |
| Myovant Sciences INC. | $12.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Cisek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.